Muñoz-Vigna RA, Olivares-Cruz S, Lecuona-Huet NE, Laparra-Escareño H, Fabián-Mijangos W, Ziga-Martínez A, Blum-Gilbert NA

Language: Spanish
References: 12
Page: 21-25
PDF size: 129.77 Kb.

ABSTRACT

Objective. Determine the prevalence of peripheral arterial disease (PAD) in general population in the 503 unit (Cardiology-Angiology-Neumology) in Hospital General de México.
Material and methods. A descriptive, cross-sectional study was reported in patients with an age > 50 years without a history of PAD. We asked about the most prevalent chronic degenerative diseases in our unit such as diabetes mellitus (DM), arterial hypertension (AH) and history of smoking. The Edinburgh questionnaire was applied to a random sample in the different specialties, and those that were positive were confirmed with the measurement of the ankle-brachial-index (ABI).
Results. A total of 200 patients were included, with a mean age of 67 years with a standard deviation (SD) = 11.6, among them 108 men and 92 women were included. We find a global prevalence of PAD of 10.5% (n = 21). The male population was presented in 12.03% (n = 13) and in women, 8.69% (n = 8). The average age of the population with the presence of EAP was 66.8 with a (SD = 9.5). Chronic degenerative diseases were included, where hypertension had a higher prevalence in the general population of 60% and a prevalence of 76.19% in patients with PAD. DM presented a prevalence of 35% in the total population and 80.95% in patients with PAD. Regarding the history of smoking, 55% of the total population and 85.71% of patients with PAD were present.
Conclusions. PAD is a poorly diagnosed disease with a high prevalence in patients with cardiovascular disease. The risk factors associated with this entity are HAS and DM. The habit of smoking represents an important risk factor in patients with CAD because it was present in more than half of the studied population and more frequently in the sick population.

REFERENCES

1. Diagnóstico y Tratamiento de la Enfermedad Arterial Periférica. México: Secretaría de Salud; 2008.

2. Ferket BS, Spronk S, Ersen B, et al. Systematic Review of Guidelines on Peripheral Artery Disease Screening. Am J Med 2012; 125(2).

3. Tendera M, AboyansV, Bartelink M-L, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases. Eur Heart J 2011; 32: 2851-906.

4. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45(1), Supplement: S5-S67.

5. Forbang NI, Hughes-Austin JN, Allison MA, et al. Peripheral Artery Disease and Non-Coronary Atherosclerosis in Hispanics: Another Paradox? Progres in Cardiovascular Diseases 2014; 57: 237-43.

6. Grau M, Baena-Díez JM, Félix-Redondo FJ, et al. Estimating the risk of peripheral artery disease using different population strategies. Preventive Medicine 2013; 57: 328-33.

7. Quintella Farah B, Mendes Ritti-Dias R, Grizzo Cucato G, et al. Effects of Clustered Comorbid Conditions on Walking Capacity in Patients with Peripheral Artery Disease. Ann Vasc Surg 2014; 28: 279-83.

8. Trujillo-Alcocer JC, Flores-Escartín MH, López-Monterrubio AR, et al. Prevalencia de la enfermedad arterial periférica en población mexicana derechohabiente del Hospital Regional Lic. Adolfo López Mateos, ISSSTE. Rev Mex Angiol 2014; 42(2): 62-7.

9. Lange SF, Trampisch H-J, Pittrow D, et al. Profound influence of different methods for determination of the ankle brachial index on the prevalence estimate of peripheral arterial disease. BMC Public Health 2007; 7: 147.

10. Rutherford’s Vascular Surgery. Chapter 16. 8th Ed. Ed Elsevier. 230-56.

11. Wouter TM, Hoes AW, Rutgers, et al. Peripheral arterial disease in the elderly. The Rotterdam Study. Arterioscler Thromb Vasc Biol 1998; 18: 185-92.

12. He Y, Jiang Y, Wang J, et al. Prevalence of peripheral arterial disease and its association with smoking in a population- based.